Skip to Content

CurePSP

Donate to CurePSP

Current Research Studies

Research Studies and Clinical Trials

  • Search for Clinical Trials!
  • Participants Needed in MSA Drug Trial

    The goal of this trial is to test if Rifampicin will prevent progression of the disease.

  • Davunetide Clinical Trial for PSP Patients

    Allon Therapeutics Inc. is underway with a clinical trial of davunetide, an investigational treatment, for patients with PSP. The purpose of this Phase 2/3 study is to assess the safety and efficacy of davunetide as a potential treatment for patients with PSP. Recruiting has closed and the study is underway.

  • PSP Patients Needed for Risk Factors Study

    Genetic and Environmental Risk Factors for PSP, sponsored by the University of Louisville and the National Institute on Aging.

  • PSP and CBD Patients Needed for Stimulation Study

    Noninvasive Cortical Stimulation (rTMS) for Motor and Non-Motor Features of Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration (CBD), sponsored by the UCLA School of Medicine.

  • Rasagiline Mesylate Clinical Trial for MSA Patients

    A Multi-centered, Randomized, Double-blind, Placebo-controlled Clinical Trial to Assess the Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P). Recruiting for this clinical trial has closed and the study is underway.